Az áttétes kasztrációrezisztens prosztatarák gyógyszer-rezisztenciájának molekuláris vonatkozásai

Translated title of the contribution: Molecular underpinnings of systemic treatment resistance in metastatic castration-resistant prostate cancer

Szarvas Tibor, Csizmarik Anita, Nagy Nikolett, Keresztes Dávid, Váradi Melinda, Küronya Zsófia, Riesz Péter, Nyirády Péter

Research output: Contribution to journalReview article

Abstract

In the last few years, several new drugs with various mechanisms of action have been approved for the treatment of castration-resistant prostate cancer. Due to this development, therapeutic decision-making has become increasingly complex. Therefore, therapy selection as well as timing and sequence of treatments need to be optimized in an individual manner. In addition, also for these novel therapies, baseline and acquired as well as cross-resistance have been observed. Underlying mechanisms become increasingly clear, resulting in a shift from empiric-based towards rational- based therapeutic decision-making. In the present review, we provide an overview on the resistance mechanisms against the most frequently applied systemic treatments of metastatic castration-resistant prostate cancer such as docetaxel, abiraterone and enzalutamide. We summarize - among others - the mechanisms by MDR (multidrugresistant) protein expression, alterations of androgen receptor, Wnt, p53 and DNA-repair pathways (BRCA/ATM) as well as resistance through therapy-induced neuroendocrine differentiation of the tumour.

Translated title of the contributionMolecular underpinnings of systemic treatment resistance in metastatic castration-resistant prostate cancer
Original languageHungarian
Pages (from-to)813-820
Number of pages8
JournalOrvosi hetilap
Volume161
Issue number20
DOIs
Publication statusPublished - May 2020

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Molecular underpinnings of systemic treatment resistance in metastatic castration-resistant prostate cancer'. Together they form a unique fingerprint.

  • Cite this